Price $15.65 |
Market Cap
766.9M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.38
|
P/S
1.14
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
8.3
|
Op. Cash Flow
132.5K
|
FCF
2.4
|
|
Op. Margin
12.70%
|
Net Margin
-0.40%
|
ROE
-0.50%
|
ROI
6.80%
|
|
ROA
-0.20%
|
EPS Growth
-103.70%
|
Current Ratio
2.0
|
Debt/Equity
159.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Xtant Medical Holdings Inc (XTNT) | $0.65 | - | - | 13.5M | Strong Buy |
| Endo International PLC (ENDP) | $8.72 | - | - | 2.49B | Strong Buy |
| Encision Inc (ECIA) | $0.43 | - | - | 4.4M | Strong Buy |
| Invo Bioscience Inc (IVOB) | $0.22 | - | - | 31.1M | Strong Buy |
| CV Sciences Inc (CVSI) | $0.23 | - | - | 22.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
